Follow the Carasent ASA share price and the full management transaction log of the company, a publicly traded company based in Norway. Shares are quoted on the NO market, under the supervision of Oslo Børs. Operating in the Health Care sector, Carasent ASA has published 22 insider filings. Market capitalisation: €1.6bn. The latest transaction was disclosed on 5 December 2024 (Other). Among the most active insiders: Svein Martin Bjørnstad. All data is accessible without an account.
22
Insider Decl.
n/a
Thresholds
€14m
19 ops.
Buy Volume
€450,487
1 ops.
Sell Volume
30Σ signal
Buys €14m€450,487 Sells
Fundamental score
Ranked 12,821 of 28,932 companies
55.0
score / 100
Value
38
Quality
72
FCF yld-0.0%
Earn yld2.1%
EV/EBITDA17.3x
ROE5.2%
Gross mgn84%
Net mgn10%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,000 shares@ NOK 36.602.3% of flowShareXOSLOSLO:525622
22 of 22 declarations
About Carasent ASA
Carasent ASA is a Norwegian company operating in the healthcare and pharmaceutical sector. It is listed on the Oslo Stock Exchange under the symbol XOSL.